Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting

BACKGROUND/AIMS: Limited data exist comparing the safety and efficacy of direct-acting antivirals (DAAs) in hepatitis C virus (HCV) monoinfected and HCV/human immunodeficiency virus (HIV) coinfected patients in the real-world clinic practice setting. METHODS: All HCV monoinfected and HCV/HIV coinfec...

Descripción completa

Detalles Bibliográficos
Autores principales: Gayam, Vijay, Hossain, Muhammad Rajib, Khalid, Mazin, Chakaraborty, Sandipan, Mukhtar, Osama, Dahal, Sumit, Mandal, Amrendra Kumar, Gill, Arshpal, Garlapati, Pavani, Ramakrishnaiah, Sreedevi, Mowyad, Khalid, Sherigar, Jagannath, Mansour, Mohammed, Mohanty, Smruti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254621/
https://www.ncbi.nlm.nih.gov/pubmed/29938459
http://dx.doi.org/10.5009/gnl18004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254621/
https://www.ncbi.nlm.nih.gov/pubmed/29938459
http://dx.doi.org/10.5009/gnl18004

Ejemplares similares